TY - JOUR
T1 - Gut-derived short-chain fatty acids modulate skin barrier integrity by promoting keratinocyte metabolism and differentiation
AU - Trompette, Aurélien
AU - Pernot, Julie
AU - Perdijk, Olaf
AU - Alqahtani, Rayed Ali A.
AU - Domingo, Jaime Santo
AU - Camacho-Muñoz, Dolores
AU - Wong, Nicholas C.
AU - Kendall, Alexandra C.
AU - Wiederkehr, Andreas
AU - Nicod, Laurent P.
AU - Nicolaou, Anna
AU - von Garnier, Christophe
AU - Ubags, Niki D.J.
AU - Marsland, Benjamin J.
N1 - Funding Information:
We are grateful to Janine Horlbeck, Jean-Christophe Stehle, and Jeremiah Bernier-Latmani for assistance with skin H&E and immunohistochemistry staining, to Julijana Ivanisevic and Hector Gallart Ayala for the isotopic profiling and metabolomics studies, to the Lausanne Genomics Technologies Facility for library preparation and RNA sequencing, and to Jean Daraspe (Electron Microscopy Facility, University of Lausanne, Switzerland) for assistance with processing and acquisition of TEM micrographs of HEK cultures. We would like to thank NonLinear Dynamics/Waters for their support (Laboratory for Lipidomics and Lipid Biology, University of Manchester).
Funding Information:
This work was supported by fellowships to B.J.M. from the National Health and Medical Research Council (NHMRC), Australia (Grant number 1154344) and the Victorian Endowment for Science, Knowledge, and Innovation (VESKI). O.P. is supported by the Longfonds (Netherlands) as part of the AWWA (A World Without Asthma) consortium. Open Access funding enabled and organized by CAUL and its Member Institutions.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/5
Y1 - 2022/5
N2 - Barrier integrity is central to the maintenance of healthy immunological homeostasis. Impaired skin barrier function is linked with enhanced allergen sensitization and the development of diseases such as atopic dermatitis (AD), which can precede the development of other allergic disorders, for example, food allergies and asthma. Epidemiological evidence indicates that children suffering from allergies have lower levels of dietary fibre-derived short-chain fatty acids (SCFA). Using an experimental model of AD-like skin inflammation, we report that a fermentable fibre-rich diet alleviates systemic allergen sensitization and disease severity. The gut-skin axis underpins this phenomenon through SCFA production, particularly butyrate, which strengthens skin barrier function by altering mitochondrial metabolism of epidermal keratinocytes and the production of key structural components. Our results demonstrate that dietary fibre and SCFA improve epidermal barrier integrity, ultimately limiting early allergen sensitization and disease development. The Graphical Abstract was designed using Servier Medical Art images (https://smart.servier.com).[Figure not available: see fulltext.]
AB - Barrier integrity is central to the maintenance of healthy immunological homeostasis. Impaired skin barrier function is linked with enhanced allergen sensitization and the development of diseases such as atopic dermatitis (AD), which can precede the development of other allergic disorders, for example, food allergies and asthma. Epidemiological evidence indicates that children suffering from allergies have lower levels of dietary fibre-derived short-chain fatty acids (SCFA). Using an experimental model of AD-like skin inflammation, we report that a fermentable fibre-rich diet alleviates systemic allergen sensitization and disease severity. The gut-skin axis underpins this phenomenon through SCFA production, particularly butyrate, which strengthens skin barrier function by altering mitochondrial metabolism of epidermal keratinocytes and the production of key structural components. Our results demonstrate that dietary fibre and SCFA improve epidermal barrier integrity, ultimately limiting early allergen sensitization and disease development. The Graphical Abstract was designed using Servier Medical Art images (https://smart.servier.com).[Figure not available: see fulltext.]
UR - http://www.scopus.com/inward/record.url?scp=85131590897&partnerID=8YFLogxK
U2 - 10.1038/s41385-022-00524-9
DO - 10.1038/s41385-022-00524-9
M3 - Article
C2 - 35672452
AN - SCOPUS:85131590897
SN - 1933-0219
VL - 15
SP - 908
EP - 926
JO - Mucosal Immunology
JF - Mucosal Immunology
IS - 5
ER -